CompletedPHASE2, PHASE3NCT00146718

Anti-Malarial Drug Resistance in Cameroon

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
London School of Hygiene and Tropical Medicine
Principal Investigator
Wilfred Mbacham, ScD
Laboratory for Public Health Biotechnology, University of Yaounde I
Intervention
Amodiaquine and Sulphadoxine/Pyrimethamine(drug)
Enrollment
755 target
Eligibility
All sexes
Timeline
20032005

Collaborators

University of Yaounde

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00146718 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials